Introduction
The polycystic ovary syndrome (PCOS) is a heterogeneous condition, the pathophysiology of which appears to be both multifactorial and polygenic. The definition of the syndrome has been much debated. Key features include menstrual cycle disturbance, hyperandrogenism and obesity. There are many extra-ovarian aspects to the pathophysiology of PCOS, yet ovarian dysfunction is central. At a joint ASRM/ESHRE consensus meeting, a refined definition of the PCOS was agreed, in which two out of the following are required: N oligomenorrhoea or amenorrhoea; N clinical and/or biochemical signs of hyperandrogenism; N polycystic ovaries, once appropriate tests have been performed to exclude other causes of androgen excess and menstrual disturbance. 1 According to the available literature, the criteria fulfilling sufficient specificity and sensitivity to define the polycystic ovary (PCO) should have at least one of the following: either 12 or more follicles measuring 2-9 mm in diameter or increased ovarian volume (.10 cm 3 ). If there is a follicle .10 mm in diameter, the scan should be repeated at a time of ovarian quiescence in order to calculate volume and area. The presence of a single PCO is sufficient to provide the diagnosis. The distribution of follicles and a description of the stroma are not required in the diagnosis. 2 Increased stromal echogenicity and/or stromal volume are specific to PCO, but it has been shown that the measurement of ovarian volume (or area) is a good surrogate for quantification of the stroma in clinical practice.
From this, the diagnosis of PCO as an ultrasound finding, could be (asymptomatic PCO) and does not necessitate a diagnosis of PCOS, unless associated with the clinical picture of anovulation disorder and/or hyperandrogenism to fulfil the definition of the PCOS. 2
What is PCOS?
PCOS is a syndrome of ovarian dysfunction associated with complex endocrine and metabolic dysfunction. Its cardinal features are menstrual irregularities, hyperandrogenism and polycystic ovarian morphology. Other associations may include elevated serum LH concentrations, obesity, insulin resistance and increased risk of type 2 diabetes. [3] [4] [5] Early studies identified the association of certain endocrine abnormalities in women with of polycystic ovaries. Raised serum levels of LH, testosterone and androstenedione, in association with low or normal levels of FSH, described an endocrine profile, which many believed to be diagnostic of PCOS. 6 Since the new definition has been introduced the elevated LH/FSH ratio is no longer a diagnostic feature of PCOS. There is considerable heterogeneity of symptoms and signs, and biochemical features amongst women with PCOS and, for an individual, these may change over time. 7, 8 The 1990 National Institute of Health Conference on PCOS, however, recommended that diagnostic criteria should include evidence of hyperandrogenism and ovulatory dysfunction, in the absence of non-classic adrenal hyperplasia, and that evidence of polycystic ovarian morphology was not essential. It has been considered necessary to redefine PCOS and to include within it an appropriate definition of the polycystic ovary. 9, 10 It is now recognized that women with regular cycles and hyperandrogenism, and/or PCO may be part of the syndrome. [11] [12] [13] It has also been recognized that some women with the syndrome will have PCO without clinical evidence of androgen excess, but will display evidence of ovarian dysfunction. PCOS remains a syndrome and, as such, no single diagnostic criterion (such as hyperandrogenism or PCO alone) is sufficient for clinical diagnosis.
What is a PCO?
Numerous descriptions have been made of the morphology of the polycystic ovary and these have been refined over time, alongside advances in imaging technology. Stein & Leventhal (1935) 14 from histological specimens taken at wedge resection of the ovaries. The histopathological criteria have been defined as the observation of atretic follicles and/or degenerating granulosa cells, hypertrophy and luteinization of the inner theca cell layer and thickened ovarian tunica. Good correlation has been shown between ultrasound diagnoses of polycystic morphology and the histopathological criteria for polycystic ovaries by studies examining ovarian tissue obtained at hysterectomy or after wedge resection. 15, 16 Swanson et al. 17 were the first to use high-resolution realtime ultrasound (static B-scanner 3 . 5 MHz, transabdominal) to describe polycystic ovaries. Prior to this, it was thought that the tiny cysts/follicles of the polycystic ovary could not be detected by ultrasound. The follicles were noted to be 2-6 mm in diameter, but the number of follicles was neither recorded nor defined. Stromal characteristics were not described.
The transabdominal ultrasound criteria of Adams 11 attempted to define a polycystic ovary as one that contains, in one plane, at least 10 follicles (usually between 2 and 8 mm in diameter) arranged peripherally around a dense core of ovarian stroma or scattered throughout an increased amount of stroma. This was a seminal paper that has been most often quoted in the literature on the PCOS.
Transvaginal ultrasound has superseded transabdominal scanning because of greater resolution. The transvaginal approach gives a more accurate view of the internal structure of the ovaries, avoiding apparently homogeneous ovaries as described with transabdominal scans, particularly in obese patients. With the transvaginal route, high frequency probes (.6 MHz) having a better spatial resolution, but less examination depth can be used because the ovaries are close to the vagina and/or the uterus and because the presence of fatty tissue is usually less disruptive (except when very abundant).
Jonard et al. 18 studied 214 women with PCOS (oligo-/ amenorrhoea, elevated serum LH and/or testosterone, and/or ovarian area .5 . 5 cm 2 ) and 112 with normal ovaries to determine the importance of follicle number per ovary (FNPO). A 7 MHz transvaginal ultrasound scan was performed and three different categories of follicle size analysed separately (2-5, 6-9 and 2-9 mm). Size range of the follicles has been considered important by some, with polycystic ovaries tending to have smaller follicles than normal or multicystic ovaries. 19, 20 The mean FNPO was similar between normal and polycystic ovaries in the 6-9 mm range, but significantly higher in the polycystic ovaries in both the 2-5 and 2-9 mm ranges. A FNPO of >12 follicles 2-9 mm gave the best threshold for the diagnosis of PCOS (sensitivity 75%, specificity 99%). 18 The authors suggest that intra-ovarian hyperandrogenism promotes excessive early follicular growth up to 2-5 mm, with more follicles able to enter the growing cohort, which then become arrested at the 6-9 mm size.
The increased echo density of the ovarian stroma in a polycystic ovary is a key histological feature, 19 but is a subjective assessment that may vary depending upon the setting of the ultrasound machine and the patient's body habitus. However, evidence suggest that ovarian volume correlates well with ovarian function, and is both more easily and reliably measured in routine practice than ovarian stroma. Thus, in order to define the polycystic ovary neither qualitative nor quantitative assessment of the ovarian stroma is required. Furthermore, the presence of a single PCO is sufficient to provide the diagnosis. The distribution of follicles and a description of the stroma are not required in the diagnosis. Three-dimensional and Doppler ultrasound studies may be useful research tools, but are not required in the definition of PCO. 2 Technical recommendations are advised and, whenever possible, the transvaginal approach should be preferred, particularly in obese patients. State-of-the-art equipment is required and should be operated by appropriately trained personnel. The ideal time to scan women with regular periods is in the early follicular phase (days 3-5). Oligo-/amenorrhoeic women should be scanned either at random or between days 3-5 after a progestogen-induced bleed. If there is evidence of a dominant follicle (.10 mm) or a corpus luteum, the scan should be repeated the next cycle. Calculation of ovarian volume is performed using the simplified formula for a prolate ellipsoid (0 . 56length6width6thickness). Follicle number should be estimated both in longitudinal and antero-posterior cross-sections of the ovaries. Follicle size should be expressed as the mean of the diameters measured in the two sections.
The ultrasound assessment always provides the opportunity to measure endometrial thickness. Women with PCOS have excess oestrogen, which promotes endometrial growth. The endometrium will only be shed as a result of progesterone secretion after ovulation. Amenorrhoeic women are therefore at risk of endometrial hyperplasia, which in time can develop into adenocarcinoma, particularly premenopausal women. 21 Attention should therefore be paid to endometrial thickness and morphology during the ultrasound scan.
Summary
The PCOS is common, occurring in about 20-25% of the female population in the UK. There are also racial and genetic differences, with a greater degree of expression of PCOS in women from South Asia. Women who are overweight are at greater risk of reproductive and metabolic problems. With the rise in obesity in society we are seeing a parallel rise in PCOS. It is necessary, therefore, to be familiar both with the clinical manifestations and ultrasound morphological characteristics of women with PCOS.
